Joint Corp (JYNT) Given Consensus Rating of “Buy” by Brokerages

Joint Corp (NASDAQ:JYNT) has been assigned an average rating of “Buy” from the six brokerages that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $6.15.

Several equities research analysts have recently weighed in on JYNT shares. Zacks Investment Research cut shares of Joint from a “buy” rating to a “hold” rating in a research report on Wednesday, January 10th. ValuEngine upgraded shares of Joint from a “sell” rating to a “hold” rating in a research report on Sunday, December 31st.

Shares of Joint (NASDAQ:JYNT) opened at $5.03 on Monday. Joint has a 12-month low of $3.06 and a 12-month high of $6.00. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.32 and a current ratio of 1.32. The firm has a market cap of $68.00, a price-to-earnings ratio of -7.29 and a beta of 1.44.

Joint (NASDAQ:JYNT) last posted its quarterly earnings data on Thursday, November 9th. The company reported ($0.03) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.06) by $0.03. Joint had a negative net margin of 36.74% and a negative return on equity of 98.28%. The company had revenue of $6.55 million during the quarter, compared to analysts’ expectations of $6.28 million. research analysts anticipate that Joint will post -0.27 EPS for the current year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Russell Investments Group Ltd. boosted its stake in Joint by 28.4% during the third quarter. Russell Investments Group Ltd. now owns 112,900 shares of the company’s stock worth $538,000 after acquiring an additional 25,000 shares in the last quarter. Boston Partners boosted its stake in Joint by 25.4% during the third quarter. Boston Partners now owns 189,200 shares of the company’s stock worth $901,000 after acquiring an additional 38,300 shares in the last quarter. Finally, Skylands Capital LLC boosted its stake in Joint by 11.0% during the fourth quarter. Skylands Capital LLC now owns 612,529 shares of the company’s stock worth $3,038,000 after acquiring an additional 60,900 shares in the last quarter. Institutional investors own 45.90% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was first published by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/02/12/joint-corp-jynt-given-consensus-rating-of-buy-by-brokerages.html.

Joint Company Profile

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply